These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 35020794)

  • 1. Pharmacy benefit manager reform within Medicaid Managed Care: The pursuit of a model that preserves the intent of the 340B program.
    Almeter PJ; Butler WR; Reynolds JW; Duckworth DL; Labuhn JA; Birdwhistell MD
    Am J Health Syst Pharm; 2022 Sep; 79(18):1607-1611. PubMed ID: 35020794
    [No Abstract]   [Full Text] [Related]  

  • 2. Challenges for Managed Care from 340B Contract Pharmacies.
    Fein AJ
    J Manag Care Spec Pharm; 2016 Mar; 22(3):197-203. PubMed ID: 27003548
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of 340B contract pharmacy growth with county-level characteristics.
    Nikpay S; Gracia G; Geressu H; Conti R
    Am J Manag Care; 2022 Mar; 28(3):133-136. PubMed ID: 35404549
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anticipated efficiencies, real costs: Medicaid managed care organizations and the pharmacy benefit.
    Bendicksen L; Kesselheim AS
    J Manag Care Spec Pharm; 2022 Mar; 28(3):354-361. PubMed ID: 35199580
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A primer on managed care pharmacy.
    Happe LE; Edgar BS
    J Manag Care Spec Pharm; 2023 Dec; 29(12):1371-1376. PubMed ID: 38058142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Iowa community pharmacies' experiences with Medicaid managed care.
    Urmie JM; Murry LT; Deng H; Doucette WR
    J Am Pharm Assoc (2003); 2020; 60(4):624-630. PubMed ID: 31901442
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estimated Changes in Manufacturer and Health Care Organization Revenue Following List Price Reductions for Hepatitis C Treatments.
    Dickson S; Reynolds I
    JAMA Netw Open; 2019 Jul; 2(7):e196541. PubMed ID: 31276176
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug utilization and cost in a Medicaid population: a simulation study of community vs. mail order pharmacy.
    Valluri S; Seoane-Vazquez E; Rodriguez-Monguio R; Szeinbach SL
    BMC Health Serv Res; 2007 Jul; 7():122. PubMed ID: 17663768
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of the 340B Pharmacy Program on Services and Supports for Persons Served by Hemophilia Treatment Centers in the United States.
    Malouin RA; Mckernan L; Forsberg A; Cheng D; Drake J; McLaughlin K; Trujillo M
    Matern Child Health J; 2018 Sep; 22(9):1240-1246. PubMed ID: 29948762
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The 340b Program, Contract Pharmacies, Hospitals, and Patients: An Evolving Relationship Impacting Health Care Delivery.
    Ruley M; Belcher M; Sayre H; Coustasse A
    Health Care Manag (Frederick); 2019; 38(4):311-321. PubMed ID: 31663869
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Implementation of a $4 generic drug program in a 340B pharmacy.
    Bright DR; Adams AJ; Akala FO; Lengel AJ; Martin SJ; Powers MF
    Am J Health Syst Pharm; 2010 Jun; 67(11):929-31. PubMed ID: 20484217
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of managed care on the retail distribution of pharmaceuticals.
    Carroll NV
    Manag Care Interface; 1998 Nov; 11(11):105-8, 111-3. PubMed ID: 10187415
    [TBL] [Abstract][Full Text] [Related]  

  • 13. State and federal government mandates are changing the face of pharmacy management.
    Giaquinta D
    Manag Care Interface; 2001 May; 14(5):50-2. PubMed ID: 11385948
    [No Abstract]   [Full Text] [Related]  

  • 14. Introducing the Managed Care Pharmacy Primer Series.
    Happe LE; McCart M
    J Manag Care Spec Pharm; 2023 Dec; 29(12):1369-1370. PubMed ID: 38058140
    [No Abstract]   [Full Text] [Related]  

  • 15. Managed health care.
    Curtiss FR
    Am J Hosp Pharm; 1989 Apr; 46(4):742-63. PubMed ID: 2719053
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contract pharmacies come under 340B scrutiny.
    Traynor K
    Am J Health Syst Pharm; 2014 Apr; 71(8):608-11. PubMed ID: 24688031
    [No Abstract]   [Full Text] [Related]  

  • 17. State legislation inhibiting the operation of managed care pharmacy programs increases costs.
    Masso AR; O'Hara J
    Benefits Q; 1993; 9(3):46-51. PubMed ID: 10127198
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison of medication access services at 340B and non-340B hospitals.
    Rana I; von Oehsen W; Nabulsi NA; Sharp LK; Donnelly AJ; Shah SD; Stubbings J; Durley SF
    Res Social Adm Pharm; 2021 Nov; 17(11):1887-1892. PubMed ID: 33846100
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacy benefit management as a quality safeguard.
    Giaquinta D
    Manag Care Interface; 2002 Mar; 15(3):54, 57. PubMed ID: 11925680
    [No Abstract]   [Full Text] [Related]  

  • 20. Patterns of pharmacy participation in Medicaid: implications for enrollee access.
    Adams EK; Gavin N
    Inquiry; 1996-1997 Winter; 33(4):339-51. PubMed ID: 9031650
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.